Avinger Inc Cash Flow Conversion Efficiency
Avinger Inc cash flow conversion efficiency. Based on the latest financial reports, Avinger Inc (AVGR) has a cash flow conversion efficiency ratio of -0.738x as of September 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.86 Million) by net assets ($3.88 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Avinger Inc (2012–2023)
Cash flow conversion efficiency of Avinger Inc from 2012 to 2023. This chart illustrates how Avinger Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Avinger Inc share price for real-time trading data and today's change.
Avinger Inc Cash Flow Conversion Ratio Explained
Avinger Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Avinger Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Avinger Inc ranked by their cash flow conversion efficiency. Also see market value of Avinger Inc for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Im Cannabis Corp
NASDAQ:IMCC
|
-1.169x |
|
Westar Resources Ltd
AU:WSR
|
-0.269x |
|
Central China Real Estate Limited
F:AJ5
|
-0.088x |
|
CBEYOND
F:C5B
|
0.724x |
|
BELGRAVIA HARTFORD CAP.
F:ECA
|
1.398x |
|
Next Biometrics Group ASA
OL:NEXT
|
-1.469x |
|
Radaan Mediaworks India Limited
NSE:RADAAN
|
0.196x |
|
Montanaro UK Smaller Companies Investment Trust PLC
LSE:MTU
|
-0.012x |
Annual Cash Flow Conversion Efficiency for Avinger Inc (2012–2023)
The table below shows the annual cash flow conversion efficiency of Avinger Inc from 2012 to 2023. Review AVGR free cash flow debt coverage to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | $-6.20 Million | $-14.43 Million | 2.327x | +157.56% |
| 2022-12-31 | $4.15 Million | $-16.76 Million | -4.042x | -150.40% |
| 2021-12-31 | $9.72 Million | $-15.70 Million | -1.614x | -42.30% |
| 2020-12-31 | $13.08 Million | $-14.84 Million | -1.135x | +54.69% |
| 2019-12-31 | $6.89 Million | $-17.26 Million | -2.504x | -28.27% |
| 2018-12-31 | $9.46 Million | $-18.47 Million | -1.952x | -302.07% |
| 2017-12-31 | $-35.69 Million | $-34.48 Million | 0.966x | +107.72% |
| 2016-12-31 | $4.24 Million | $-53.07 Million | -12.513x | -377.14% |
| 2015-12-31 | $15.59 Million | $-40.88 Million | -2.623x | -1830.66% |
| 2014-12-31 | $-143.87 Million | $-21.80 Million | 0.152x | -57.96% |
| 2013-12-31 | $-112.78 Million | $-40.66 Million | 0.360x | -24.66% |
| 2012-12-31 | $-73.64 Million | $-35.23 Million | 0.478x | -- |
About Avinger Inc
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to prov… Read more